| (Values in U.S. Thousands) | Jun, 2024 | Jun, 2023 | Jun, 2022 | Jun, 2021 | Jun, 2020 |
| Sales | 226,827,000 | 205,012,000 | 181,364,000 | 162,467,000 | 152,922,000 |
| Sales Growth | +10.64% | +13.04% | +11.63% | +6.24% | +5.08% |
| Net Income | 852,000 | 261,000 | -933,000 | 611,000 | -3,696,000 |
| Net Income Growth | +226.44% | +127.97% | -252.70% | +116.53% | -371.17% |
Cardinal Health (CAH)
134.01 x 2 137.45 x 1
Pre-market by (Cboe BZX)
136.65 +2.67 (+1.99%) 03/27/25 [NYSE]
134.01 x 2 137.45 x 1
Pre-market 135.53 -1.12 (-0.82%) 04:41 ET
for Thu, Mar 27th, 2025
Cardinal Health Inc. is a nation-wide drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. The company has two reporting segments: Pharmaceutical and Medical. The Pharmaceutical segment is the second largest pharmaceutical distributor in the United States and the largest nuclear pharmacy. Its products and services include pharmaceutical distribution, manufacturer and specialty services, and nuclear and pharmacy services. The Medical segment manufactures products such as single-use surgical drapes, gowns and apparel; exam and surgical gloves; and fluid suction and collection systems and offers sterile and non-sterile procedure kits. These products are sold directly or distributed via third-party sources in the U.S., Canada, Europe, South America and the Asia/Pacific.'
Fiscal Year End Date: 06/30